GGrantIndex
← Search

Cancer Center Administration

$269,566P30FY2025CANIH

Rutgers Biomedical And Health Sciences, Newark NJ

Investigators

Linked publications, trials & patents

Trial NCT05639972Trial NCT05483491Trial NCT05296421Trial NCT04929015Trial NCT04920344Trial NCT04871516Trial NCT04751747Trial NCT04445844Trial NCT04294264Trial NCT04285268Trial NCT04253483Trial NCT04211259Trial NCT04179227Trial NCT04163952Trial NCT04146038Trial NCT04081688Trial NCT03902379Trial NCT03725449Trial NCT03677739Trial NCT03456843Trial NCT03448224Trial NCT03441321Trial NCT03428802Trial NCT03272633Trial NCT03257163Trial NCT03233555Trial NCT03229278Trial NCT03228147Trial NCT03112668Trial NCT03108911Trial NCT03102060Trial NCT03061175Trial NCT03028948Trial NCT02949284Trial NCT02885649Trial NCT02748564Trial NCT02699996Trial NCT02688517Trial NCT02688192Trial NCT02621398Trial NCT02526511Trial NCT02526498Trial NCT02458716Trial NCT02421575Trial NCT02420652Trial NCT02324621Trial NCT02324608Trial NCT02315196Trial NCT02295540Trial NCT02294617Trial NCT02250781Trial NCT02203604Trial NCT02203578Trial NCT02177838Trial NCT02144701Trial NCT02144675Trial NCT02105116Trial NCT01828476Trial NCT01694589Trial NCT01652014Trial NCT01649947Trial NCT01480154Trial NCT01417286Trial NCT01407562Trial NCT01303341Trial NCT01251172Trial NCT01032590Trial NCT01018836Trial NCT01009931Trial NCT01006369Trial NCT00996359Trial NCT00991315Trial NCT00966667Trial NCT00962845Trial NCT00946283Trial NCT00943709Trial NCT00939380Trial NCT00934895Trial NCT00909909Trial NCT00905918Trial NCT00900120Trial NCT00899808Trial NCT00899639Trial NCT00895115Trial NCT00891969Trial NCT00878657Trial NCT00866840Trial NCT00853125Trial NCT00813423Trial NCT00786682Trial NCT00770419Trial NCT00770055Trial NCT00769652Trial NCT00765765Trial NCT00749437Trial NCT00740805Trial NCT00728845Trial NCT00726596Trial NCT00669734Trial NCT00667901

Abstract

CENTER ADMINISTRATION PROJECT SUMMARY/ABSTRACT Center Administration at Rutgers Cancer Institute continues to evolve to optimize support of a consortium Comprehensive Cancer Center with statewide responsibility and a cancer program deployed across RWJBarnabas Health (RWJBH), the largest health system in the state. Key responsibilities align with expectations of NCI-designated Center Administration and the Strategic Plan. Administration continues to be led by Linda Tanzer, the Center’s senior administrative executive. Gina Londino- Greenberg was promoted to Senior Director of Research Administration. Center Administration supported many important accomplishments over this grant period, a period of dramatic growth, including 1) Budget - oversaw a 57% increase in total operating budget, including an increase in state support from $31M to $53M; 2) Space - managed planning of new 12-story, 520,000 sf cancer center; 3) Recruitment - provided support to recruit/onboard 77 new faculty; 4) Clinical Research Operations- oversaw reorganization and new hiring models for Clinical Protocol and Data Monitoring (CPDM), creation of Clinical Trials Steering Committee, ongoing Lean Six Sigma process improvement, and improved network infrastructure, leading to an 80% increase in accruals to interventional treatment trials and improved staffing levels from ~66% to 90%; 5) Peer-reviewed funding -contributed to a 23% increase, including several major awards (e.g., NCI P01CA250957 and NCI/CaResearch UK Cancer Grand Challenges award OT2CA278609). Other key accomplishments of Administration include 2021-2025 Strategic Plan development, reporting, and evaluation activities. Administration further enabled transformative initiatives, including: development of a signature cancer immunology and immunotherapy initiative; providing Leadership with enhanced data analytics capabilities; and center restructuring to implement the Integrated Practice Agreement with RWJBH (optimizing impact on research). Over the next grant period, Administration will: 1) further integrate functions with research initiatives and Centers of Excellence by appointing experienced business managers to work with science leadership; 2) restructure support for faculty affairs and mentorship, and workforce development by appointing a Director to oversee these areas; 3) oversee the operationalization of the research floor of the new Jack and Sheryl Morris Cancer Center, supervise renovations to our current main facility and coordinate occupation of that space; and 4) work with Princeton University (PU) administration to assist plans to expand research and impact on cancer related public policy by hosting new administrative circles to address common issues.

View original record on NIH RePORTER →